Skip to Main Content

Paper Details

Donor Clonal Hematopoiesis and Recipient Outcomes After Transplantation.
J Clin Oncol
76
2022
-, 102 donor clones, CH, Clonal hematopoiesis, DCL, DDX41, DDX41 mutations, DNMT3A, PATIENTS, TET2, TP53, calcineurin, chronic, donor cell leukemia, donor clones, graft-versus-host disease, hematopoietic cell, interleukin-12p70, leukemic, mutated gene, myelodysplastic syndrome, patients, relapse, variant, variant allele
Author NameAffiliation
Christopher J GibsonDana-Farber Cancer Institute
Mark FlehartyBroad Institute of MIT and Harvard
Mark FlehartyBroad Institute of MIT and Harvard
Brendan BlumenstielBroad Institute of MIT and Harvard
Brendan BlumenstielBroad Institute of MIT and Harvard
Junko TsujiBroad Institute of MIT and Harvard
Christopher D GockeSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University
Christopher D GockeJohns Hopkins University
Christopher D GockeSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University
Christopher D GockeJohns Hopkins University
Richard J JonesSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University
Richard J JonesSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University
Niall J LennonBroad Institute of MIT and Harvard
Jerome RitzDana-Farber Cancer Institute
Robert Coleman LindsleyDana-Farber Cancer Institute
  • 1 - 15

Datasets

Release 1.2